C-peptide: A new mediator of atherosclerosis in diabetes

19Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Diabetes type 2 and insulin resistance are the risk factors for cardiovascular disease. It is already known that atherosclerosis is an inflammatory disease, and a lot of different factors are involved in its onset. C-peptide is a cleavage product of proinsulin, an active substance with a number of effects within different complications of diabetes. In this paper we discuss the role of C-peptide and its effects in the development of atherosclerosis in type 2 diabetic patients. Copyright © 2012 Dusica Vasic and Daniel Walcher.

Cite

CITATION STYLE

APA

Vasic, D., & Walcher, D. (2012). C-peptide: A new mediator of atherosclerosis in diabetes. Mediators of Inflammation. https://doi.org/10.1155/2012/858692

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free